The synthetic biology market in Italy is expected to reach a projected revenue of US$ 1,575.1 million by 2033. A compound annual growth rate of 16.4% is expected of Italy synthetic biology market from 2026 to 2033.
Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc
Other key industry trends
In terms of revenue, Italy accounted for 2.5% of the global synthetic biology market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany synthetic biology market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 4,729.9 million by 2033.
Supportive policies and innovation to reduce the cost of biofuel in Italy are expected to increase advanced biofuel consumption. To meet the demand for biofuel, several companies are undertaking various strategic initiatives for market expansion.
For instance, in July 2021, Eni has signed an agreement with BASF on a joint R&D initiative to reduce CO2 emission. This partnership intends to develop a novel technology to produce advanced bio-propanol from glycerin.
This technology converted glycerin to propanol through the process of catalytic hydro treatment. This biofuel has the potential to decrease 65% to 75% greenhouse gas emissions as compared to fossil fuels. Furthermore, several companies are introducing innovative products, which is expected to fuel growth of synthetic biology market in Italy.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Synthetic Biology Market Outlook will help companies and investors design strategic landscapes.
Pcr Technology was the largest segment with a revenue share of 36.22% in 2025.
Horizon Databook has segmented the Italy synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.
Supportive policies and innovation to reduce the cost of biofuel in Italy are expected to increase advanced biofuel consumption. To meet the demand for biofuel, several companies are undertaking various strategic initiatives for market expansion.
For instance, in July 2021, Eni has signed an agreement with BASF on a joint R&D initiative to reduce CO2 emission. This partnership intends to develop a novel technology to produce advanced bio-propanol from glycerin.
This technology converted glycerin to propanol through the process of catalytic hydro treatment. This biofuel has the potential to decrease 65% to 75% greenhouse gas emissions as compared to fossil fuels. Furthermore, several companies are introducing innovative products, which is expected to fuel growth of synthetic biology market in Italy.
Italy Synthetic Biology Market Technology Outlook (Revenue, USD Million , 2021-2033)
PCR Technology
Genome Editing Technology
NGS Technology
Bioprocessing Technology
Other Technologies
Italy Synthetic Biology Market Product Outlook (Revenue, USD Million , 2021-2033)
Enzymes
Oligonucleotide/Oligo Pools and Synthetic DNA
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism
Italy Synthetic Biology Market Application Outlook (Revenue, USD Million , 2021-2033)
Healthcare
Non-healthcare
Italy Synthetic Biology Market End Use Outlook (Revenue, USD Million , 2021-2033)
Biotechnology and Pharmaceutical companies
Academic and Government Research Institutes
Others
Reasons to subscribe to Synthetic Biology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Synthetic Biology Market Outlook databook
Our clientele includes a mix of Synthetic Biology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Synthetic Biology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Synthetic Biology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.